BioPharma

18 November, 2026 | Wednesday | Analysis

Sold, Closed or Mothballed: 19 APAC Drug Manufacturing Sites That Changed Hands or Shut in 2026

Openings in this region arrive with ceremony. There is a groundbreaking, a ribbon, a minister and a press release with a capacity figure in the headline. Exits arrive as a line in an exchange filing, a statemen...

Lab

18 November, 2026 | Wednesday | News

Eppendorf and Nova Biomedical Integrate Sampling and Analysis to Automate Bioprocess Control

Eppendorf and Nova Biomedical® collaborate to integrate the Eppendorf Bioprocess Autosampler with the BioProfile FLEX2 cell culture analyzer. The integration enables automated at-line analysis of critical p...

BioTech

18 November, 2026 | Wednesday | Analysis

The 10 New Drugs Japan Expects to Sell Most: Peak-Sales Forecasts From Every 2026 NHI Listing Round

On 13 November, 16 new medicines joined Japan's National Health Insurance (NHI) price list. It was the last of the seven listing rounds Japan now runs each year, and it arrived in the quiet weeks before the gov...

Contract Services

18 November, 2026 | Wednesday | News

LOTTE Biologics Secures First Major Commercial Manufacturing Deal for Songdo Plant 1

Landmark deal validates commercial strategy and reinforces confidence in LOTTE Biologics' advanced manufacturing capabilities Establishes a commercial manufacturing partnership upon completion of...

Consumer Health

18 November, 2026 | Wednesday | News

Takeda and Zuellig Pharma Partner to Expand Medicine Access Across Three Southeast Asian Markets

Takeda and Zuellig Pharma announced a strategic regional collaboration to enhance sustainable patient access to innovative medicines and healthcare solutions across Malaysia, Indonesia and the Philippines. Effe...

Medtech

19 November, 2026 | Thursday | News

Thyroscope and TORC to Study Smartphone AI and Orbital Imaging for Thyroid Eye Disease Monitoring

Smartphone monitoring, quantitative orbital imaging and clinical data will support a planned longitudinal study and a TORC-led research database. Thyroscope (THYROSCOPE INC.) and The Orbital Radiology Center (...

Cell & Gene

19 November, 2026 | Thursday | News

Celosia Therapeutics Secures A$2 Million NSW Grant for Motor Neurone Disease Gene Therapy

Celosia Therapeutics, an Australian biotech company developing advanced gene therapies for neurodegenerative diseases, is pleased to announce that it has been awarded $2 million by the New South Wales Governmen...


Biopharma APAC Infomercial

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close